NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$14.05
-0.0500 (-0.355%)
At Close: Apr 30, 2024
Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation
09:05am, Thursday, 18'th May 2023
Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and Ajovy as well as generics, further innovation, and focused c
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales
09:15am, Wednesday, 10'th May 2023
Teva Pharmaceutical reported lighter-than-expected earnings for the first quarter, leading Teva stock to plunge early Wednesday. The post Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat S
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential
09:59pm, Tuesday, 25'th Apr 2023
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential.
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
12:00pm, Tuesday, 18'th Apr 2023
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
08:56am, Saturday, 15'th Apr 2023
In theory, the stock of companies that make generic drugs have the potential to be safe investments. Despite that, companies like Teva Pharmaceuticals aren't actually safe at all.
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
04:15pm, Friday, 14'th Apr 2023
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2023 financial results on Wednesday
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
11:26am, Friday, 14'th Apr 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
08:00am, Wednesday, 05'th Apr 2023
Millions of people are scrambling to navigate the Adderall shortage in a saga closely watched by investors in Teva and other drug stocks. Here's what you should know.
Generic drugs are most likely to face shortages due to market failures in affordability
05:26pm, Wednesday, 29'th Mar 2023
CNBC's Meg Tirrell joins 'Closing Bell Overtime' to discuss growing pharmaceutical shortages, increasing debt hindering generic drug availability, and more.
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
7 Strong Buy Stocks Under $10 to Snap Up Now
06:30am, Thursday, 23'rd Mar 2023
Investors looking for a bargain and potential upside have strong buy stocks under $10 to consider. Investors should snap up companies that have value without sacrificing quality or growth.
Better Generics Pharmaceutical Stock: Teva or Viatris?
11:28am, Sunday, 05'th Mar 2023
Teva is the world's largest maker of generic drugs. Viatris offers an above-average dividend yield.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
12:03pm, Friday, 03'rd Mar 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
06:01pm, Wednesday, 22'nd Feb 2023
Dear Investor:
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
08:19am, Tuesday, 21'st Feb 2023 Benzinga
With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects The Home Depot, Inc. (NYSE: HD) to post quarterly ea